Finally, ALDH2 expression did not correlate with the tumor volume; however, it was described as a part of a gene signature that can be used to predict the visibility of PCa on magnetic resonance imaging (MRI) scans and the biochemical recurrence-free survival [108]. Here, ALDH2 is linked to posterior cortical atrophy.